Background Real-life data is very useful for gaining a better understanding of care in practice and identifying areas for ...

A multicenter study has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death. A multicenter study led by Vanderbilt University Medical Center ...

Six-month clinical data from 40 patients highlights safety, effective decongestion, stable renal function, and reduced ...

Empagliflozin improves cardiovascular outcomes in patients with heart failure, patients with type 2 diabetes who are at high cardiovascular risk, and patients with chronic kidney disease. The safety ...

Following an acute heart attack, pathological remodeling processes occur in the heart. One consequence is so-called left ...

Patients born with heart defects experience their first acute heart attack at a significantly earlier age than others. This ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

CHICAGO, IL—Spironolactone given to patients who have undergone PCI following an acute myocardial infarction has no impact on death from cardiovascular causes, or on a range of cardiovascular events ...

Rheumatic heart disease is a serious complication of Group A Streptococcus infection. It can cause damage to the valves in your heart and may cause severe heart problems in the future. Rheumatic heart ...